文献速递脑血管病外科

脑动静脉畸形立体定向放射外科治疗前栓塞的效果:倾向性评分匹配的病例对照研究

Effect of embolization before stereotactic radiosurgery for brain arteriovenous malformations: a case-control study with propensity score matching.
PubMed 文献 · J Neurosurg · 2022-09-09

本研究纳入704例未接受过手术或放疗的脑动静脉畸形患者,其中593例仅接受立体定向放射外科(SRS)治疗,111例接受栓塞后SRS(E+SRS)治疗。采用倾向性评分1:1匹配后每组98例,比较畸形血管巢闭塞率、累积出血率及囊肿形成或慢性包裹性血肿发生率。匹配后两组畸形血管巢闭塞率无显著差异(p=0.24),累积出血率及晚期放射不良反应发生率亦无显著差异。

要点

  • E+SRS组88%的患者使用n-丁基-2-氰基丙烯酸酯进行栓塞。
  • 未匹配队列中,SRS-only组3年、5年、8年畸形血管巢闭塞率分别为49.6%、69.4%、74.1%,E+SRS组分别为30.7%、50.9%、68.6%(p=0.001)。
  • 匹配后每组98例,SRS-only组3年、5年、8年闭塞率分别为47.1%、62.0%、69.6%,E+SRS组分别为32.5%、55.3%、75.0%(p=0.24)。

核心结论

  • SRS前栓塞未影响接受SRS治疗的脑动静脉畸形患者的畸形血管巢闭塞率、累积出血率或囊肿形成或慢性包裹性血肿作为晚期放射不良反应的发生率。

研究设计与样本

  • 共评估704例未接受过手术或放疗的合格脑动静脉畸形患者,其中593例仅接受SRS治疗,111例接受栓塞后SRS(E+SRS)治疗。
  • 采用倾向性评分匹配以1:1比例消除基本特征差异,匹配后每组98例。

主要发现

  • 未匹配队列中,单次SRS后3年、5年、8年畸形血管巢闭塞率在SRS-only组分别为49.6%、69.4%、74.1%,在E+SRS组分别为30.7%、50.9%、68.6%(p=0.001)。
  • 匹配队列中,3年、5年、8年闭塞率在SRS-only组分别为47.1%、62.0%、69.6%,在E+SRS组分别为32.5%、55.3%、75.0%(p=0.24)。
  • 两组间累积出血率、囊肿形成或慢性包裹性血肿发生率均无显著差异。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of this study was to evaluate whether endovascular embolization prior to stereotactic radiosurgery (SRS) has a negative impact on nidus obliteration for patients with arteriovenous malformations (AVMs). METHODS: A total of 704 eligible patients with AVM who did not undergo prior surgery or radiotherapy were evaluated. Of these patients, 593 were treated with SRS only, and 111 were treated with embolization followed by SRS (E+SRS). Most patients in the E+SRS group (88%) underwent embolization with n-butyl-2-cyanoacrylate. In the comparison of radiosurgical outcomes between patients treated with SRS only and E+SRS, these groups were matched in a 1:1 ratio using propensity score matching to eliminate differences in basic characteristics. The primary outcome was to compare the nidus obliteration rates between the SRS-only and E+SRS groups. The secondary outcomes were the comparison of cumulative hemorrhage rates and the incidence of cyst formation or chronic encapsulated hematoma after SRS between these groups. RESULTS: In the unmatched cohorts, the actuarial 3-, 5-, and 8-year nidus obliteration rates after a single SRS session were 49.6%, 69.4%, and 74.1% in the SRS-only group, respectively, and 30.7%, 50.9%, and 68.6% in the E+SRS group, respectively (p = 0.001). In the matched cohort of 98 patients in each group, the rates were 47.1%, 62.0%, and 69.6% in the SRS-only group and 32.5%, 55.3%, and 75.0% in the E+SRS group, respectively (p = 0.24). There was no significant difference in either cumulative hemorrhage or the incidence of cyst formation or chronic encapsulated hematoma between the groups. CONCLUSIONS: Pre-SRS embolization did not affect nidus obliteration rates, cumulative hemorrhage rates, or the incidence of cyst formation or chronic encapsulated hematoma as late adverse radiation effects in patients with AVM treated with SRS.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Hasegawa T, Kato T, Naito T, et al. Effect of embolization before stereotactic radiosurgery for brain arteriovenous malformations: a case-control study with propensity score matching. J Neurosurg. 2022. PMID: 36087321. doi:10.3171/2022.7.JNS221343

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。